Neurology and therapy

· 4 papers in corpus
observational 2026
doi:10.1007/s40120-026-00961-9 ·PMID:42154195

INTRODUCTION: Atogepant is an oral calcitonin gene-related peptide (CGRP) receptor antagonist approved for migraine prevention; however, real-world data from the Middle East and North Africa (MENA) region remain limited. This study evaluate…

observational 2025
doi:10.1007/s40120-025-00824-9 ·PMID:40913749

INTRODUCTION: Migraine headache not only is associated with high levels of suffering but also represents a considerable socioeconomic challenge. It is linked to various psychological and physiological impairments, including sensorimotor and…

review 2025
doi:10.1007/s40120-025-00720-2 ·PMID:40085393

Migraine affects women three times more often than it does men, and various mechanisms may explain this incidence, including the key role of female sex hormones. Fluctuations in the levels of these hormones and their feedback control regula…

review 2023
doi:10.1007/s40120-023-00439-y ·PMID:36746871

INTRODUCTION: Multiple sclerosis (MS) is mainly diagnosed in women of reproductive age. However, there is a paucity of guidelines jointly prepared by neurologists and gynaecologists on managing women with MS and the desire for motherhood. T…